[Federal Register Volume 65, Number 119 (Tuesday, June 20, 2000)]
[Notices]
[Pages 38292-38293]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-15431]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Biological Response Modifiers Advisory Committee; Notice of 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration

[[Page 38293]]

(FDA). The meeting will be open to the public.
    Name of Committee: Biological Response Modifiers Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on July 13, 2000, 8:30 a.m. 
to 6 p.m. and July 14, 2000, 8:30 a.m. to 3 p.m.
    Location: Hilton Hotel, 620 Perry Pkwy., Gaithersburg, MD.
    Contact Person: Gail Dapolito or Rosanna Harvey (HFM-71), Food and 
Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-
0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-
443-0572 in the Washington, DC area), code 12389. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: On July 13 and 14, 2000, the committee will discuss product 
development issues related to human stem cells as cellular replacement 
therapies for neurological disorders.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by June 30, 2000. 
Oral presentations from the public will be scheduled between 
approximately 9 a.m. and 10 a.m. on July 14, 2000. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before June 30, 2000, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: June 9, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-15431 Filed 6-19-00; 8:45 am]
BILLING CODE 4160-01-F